Iwatsuki-minami Hospital
About Iwatsuki-minami Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Boehringer Ingelheim
2
Associations for Establishment of Evidence in Interventions
1
Clinical Trials at Iwatsuki-minami Hospital
During the past decade, Iwatsuki-minami Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Maintenance Treatment of Renal Anemia in Dialysis Subjects
2018-06-23
2019-12-24
Completed
229
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Iwatsuki-minami Hospital"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Iwatsuki-minami Hospital
According to Clinical.Site data, the most researched conditions in "Iwatsuki-minami Hospital" are
"Heart Failure" (2 trials), "Anemia" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Iwatsuki-minami Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Iwatsuki-minami Hospital
Most popular intervention types in "Iwatsuki-minami Hospital" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Iwatsuki-minami Hospital
The vast majority of trials in "Iwatsuki-minami Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Iwatsuki-minami Hospital
Currently, there are NaN active trials in "Iwatsuki-minami Hospital".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Iwatsuki-minami Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Iwatsuki-minami Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".